Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

5.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.9K
Coagulation01:09

Coagulation

5.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.1K
Introduction to Hemostasis01:05

Introduction to Hemostasis

6.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.0K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

4.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

625
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
625
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

4.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Malignant epithelial states drive immune dysfunction in ampulla of Vater carcinoma.

Biomarker research·2026
Same author

Morphologic Features and Clinical Outcomes of Acinar Cell Carcinoma of the Pancreas: A Multicenter Retrospective Study of 37 Patients in South Korea.

Current oncology (Toronto, Ont.)·2026
Same author

Lewis antigen and antibody testing as practical first-line approaches for detecting CA19-9 non-producers.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same author

S100 Calcium-Binding Protein P Predicts Early Recurrence and Poor Survival in Distal Cholangiocarcinoma: A Proteomics Study.

Journal of proteome research·2026
Same author

Enhanced multicancer screening assay through whole-genome methylation sequencing-based multimodal cell-free DNA analysis.

Experimental & molecular medicine·2026
Same author

Sex-specific prognostic value of triceps skinfold thickness and albumin in pancreatic cancer.

iScience·2026
Same journal

Primary breast follicular lymphoma without a BCL2 rearrangement: insights into extranodal lymphoma biology.

Blood research·2026
Same journal

Nuanced treatment decision in newly diagnosed multiple myeloma patients aged 65-75 years: a real-world study.

Blood research·2026
Same journal

Novel treatment strategies in acute myeloid leukemia.

Blood research·2026
Same journal

Cross-cultural validation and reliability of the Korean version of the Haemophilia Activities List.

Blood research·2026
Same journal

Infectious complications after CAR T-cell therapy: mechanisms, risk stratification, and prevention.

Blood research·2026
Same journal

Allogeneic stem cell transplantation for myelofibrosis in the modern era: Single-center outcomes with DIPSS risk stratification.

Blood research·2026
查看所有相关文章

相关实验视频

Updated: Jun 9, 2025

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.7K

回到基本知识:凝血路径.

Seonyang Park1, Joo Kyung Park2

  • 1Department of Internal Medicine, Inje University Haeundae Paik Hospital, 875 Haeundae-Ro, Haeundae-Gu, Busan, 48108, Korea. seonpark@snu.ac.kr.

Blood research
|October 28, 2024
PubMed
概括
此摘要是机器生成的。

凝血级联包括启动,放大和传播步骤. 虽然组织因子通路对于启动凝血至关重要,但接触激活系统有助于血栓形成,但对血液静止不必.

关键词:
凝血是凝固的过程.凝固途径的凝固途径血液静止 血液静止 血液静止

更多相关视频

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

8.8K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

185

相关实验视频

Last Updated: Jun 9, 2025

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.7K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

8.8K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

185

科学领域:

  • 血液学 血液学 血液学
  • 生物化学 生物化学
  • 生理学 生理学 生理学

背景情况:

  • 经典的凝血级联模型已经发展,详细说明了内在和外在的途径.
  • 凝血涉及组织因子 (TF) 的启动,通过内在张力复合体的放大,并在激活的血小板上传播.

研究的目的:

  • 阐明修改的凝血级联的复杂步骤和组件.
  • 区分组织因子通路和接触激活系统在血液静止和血栓形成中的作用.

主要方法:

  • 关于凝血途径的既定知识的审查和综合.
  • 对凝血因子的顺序激活和复杂形成的分析.

主要成果:

  • TF-FVIIa启动凝血,通过前热血酶复合体 (FXa-FVa) 形成血栓.
  • 内在张力酶复合体 (FVIIIa-FIXa) 显著放大了血栓生成.
  • 由FXII启动的接触激活系统有助于血栓形成,但对血液静止不至关重要.

结论:

  • 凝血级联是一个多步骤的过程,涉及不同的启动,放大和传播阶段.
  • 接触激活通路在血栓事件中起作用,与其在初级血液静止中的必要性不同.